Supplements and Featured Publications
Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
A Personalized Approach to Disease Management in Psoriasis
From Evidence to Implementation: Clarifications Around the US Preventive Services Task Force Recommendations for HIV Pre-Exposure Prophylaxis
Advancing the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema With Novel and Emerging Monoclonal Antibody Therapy
Volume: 28
Issue: 3
Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Optimizing Outcomes in Multiple Sclerosis Through Individualized Treatment: Managed Care Considerations
Exclusive Coverage of the 63rd American Society of Hematology Meeting & Exposition
Coverage of the 63rd American Society of Hematology Meeting & Exposition, which took place in a hybrid format.
Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis
The Underrecognized Burden of Atopic Dermatitis in the United States
Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion
Management of TRK Fusion Cancer: Evaluating Targeted Therapies
Volume: 28
Issue: 2
Addressing the Individualized Needs in Hereditary Angioedema: Managed Care Strategies to Optimize Access to Care
Volume: 28
Issue: 1
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
